Ho Won Kang

1.9k total citations
104 papers, 1.4k citations indexed

About

Ho Won Kang is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Ho Won Kang has authored 104 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Pulmonary and Respiratory Medicine, 45 papers in Surgery and 40 papers in Molecular Biology. Recurrent topics in Ho Won Kang's work include Bladder and Urothelial Cancer Treatments (41 papers), Urinary and Genital Oncology Studies (22 papers) and Prostate Cancer Treatment and Research (16 papers). Ho Won Kang is often cited by papers focused on Bladder and Urothelial Cancer Treatments (41 papers), Urinary and Genital Oncology Studies (22 papers) and Prostate Cancer Treatment and Research (16 papers). Ho Won Kang collaborates with scholars based in South Korea, United States and China. Ho Won Kang's co-authors include Seok Joong Yun, Wun‐Jae Kim, Won Tae Kim, Sang‐Cheol Lee, Yong‐June Kim, Yung Hyun Choi, Yun‐Sok Ha, Pildu Jeong, Tae Gyun Kwon and Ye‐Hwan Kim and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Journal of Materials Chemistry A.

In The Last Decade

Ho Won Kang

101 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ho Won Kang South Korea	21	593	563	429	325	257	104	1.4k
Koji Mitsuzuka Japan	22	424 0.7×	761 1.4×	333 0.8×	214 0.7×	215 0.8×	117	1.5k
Carsten Kempkensteffen Germany	27	1.1k 1.9×	901 1.6×	470 1.1×	568 1.7×	236 0.9×	102	2.2k
Marcella Baldewijns Belgium	20	858 1.4×	622 1.1×	205 0.5×	389 1.2×	301 1.2×	62	1.6k
Kiminobu Arima Japan	22	482 0.8×	733 1.3×	393 0.9×	147 0.5×	225 0.9×	115	1.4k
Taro Iguchi Japan	18	230 0.4×	1.2k 2.2×	168 0.4×	403 1.2×	314 1.2×	69	1.6k
Steffen Rausch Germany	21	497 0.8×	564 1.0×	476 1.1×	257 0.8×	292 1.1×	122	1.4k
N. Doumerc France	21	735 1.2×	749 1.3×	486 1.1×	76 0.2×	154 0.6×	98	1.6k
Fumiya Hongo Japan	17	435 0.7×	342 0.6×	152 0.4×	182 0.6×	217 0.8×	108	973
Manish Vira United States	20	693 1.2×	1.0k 1.8×	281 0.7×	288 0.9×	148 0.6×	53	1.4k
Silvano Palazzo Italy	17	272 0.5×	376 0.7×	274 0.6×	166 0.5×	90 0.4×	45	1.0k

Countries citing papers authored by Ho Won Kang

Since Specialization

Citations

This map shows the geographic impact of Ho Won Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ho Won Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ho Won Kang more than expected).

Fields of papers citing papers by Ho Won Kang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ho Won Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ho Won Kang. The network helps show where Ho Won Kang may publish in the future.

Co-authorship network of co-authors of Ho Won Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Ho Won Kang. A scholar is included among the top collaborators of Ho Won Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ho Won Kang. Ho Won Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ha, Yun‐Sok, Mina Kim, Won Tae Kim, et al.. (2025). Incidence and mortality of upper tract urothelial carcinoma in Korea: A nationwide population-based study conducted from 2002 to 2020. Investigative and Clinical Urology. 66(1). 11–11.

Kang, Ho Won, Young Joon Byun, Won Tae Kim, et al.. (2025). Optimizing extraction of microbial DNA from urine: Advancing urinary microbiome research in bladder cancer. Investigative and Clinical Urology. 66(3). 272–272.

Lee, Hyuntae, Ho Won Kang, Mingyu Lee, et al.. (2024). A hydrophilic Janus-faced separator with functionalized nanocarbon for stable cycling of aqueous Zn-metal batteries. Journal of Materials Chemistry A. 12(6). 3623–3632. 7 indexed citations

Cho, Yoon Ah, Ji‐Young Choe, Ji Won Park, et al.. (2023). Expression of Peptidyl Arginine Deiminase 2 Is Closely Associated with Recurrence in Patients with Hepatocellular Carcinoma. Diagnostics. 13(4). 659–659. 3 indexed citations

Byun, Young Joon, Ho Won Kang, Won Tae Kim, et al.. (2023). COL6A1 expression as a potential prognostic biomarker for risk stratification of T1 high grade bladder cancer: Unveiling the aggressive nature of a distinct non-muscle invasive subtype. Investigative and Clinical Urology. 65(1). 94–94. 2 indexed citations

Kang, Ho Won, Young Joon Byun, Kyeong Kim, et al.. (2022). Urinary hsv2-miR-H9 to hsa-miR-3659 ratio is an effective marker for discriminating prostate cancer from benign prostate hyperplasia in patients within the prostate-specific antigen grey zone. Investigative and Clinical Urology. 63(2). 238–238. 6 indexed citations

Lee, Eun Hye, Jae-Wook Chung, Bo Hyun Yoon, et al.. (2022). Anti-Metastatic Effect of Pyruvate Dehydrogenase Kinase 4 Inhibition in Bladder Cancer via the ERK, SRC, and JNK Pathways. International Journal of Molecular Sciences. 23(21). 13240–13240. 10 indexed citations

Chung, Jae-Wook, Yun‐Sok Ha, Seung Chol Park, et al.. (2021). The prognostic value of the pretreatment serum albumin to globulin ratio for predicting adverse pathology in patients undergoing radical prostatectomy for prostate cancer. Investigative and Clinical Urology. 62(5). 545–545. 9 indexed citations

Byun, Young Joon, Ho Won Kang, Xuan‐Mei Piao, et al.. (2021). Expression of hsv1-miR-H18 and hsv2-miR-H9 as a field defect marker for detecting prostate cancer. Prostate International. 10(1). 1–6. 4 indexed citations

10.

Byun, Young Joon, Xuan‐Mei Piao, Pildu Jeong, et al.. (2021). Urinary microRNA-1913 to microRNA-3659 expression ratio as a non-invasive diagnostic biomarker for prostate cancer. Investigative and Clinical Urology. 62(3). 340–340. 17 indexed citations

11.

Li, Quan, Tengfei Zhang, Feng Li, et al.. (2020). Acute Kidney Injury Can Predict In-Hospital Mortality in Elderly Patients with COVID-19 in the ICU: A Single-Center Study. SHILAP Revista de lepidopterología. 1 indexed citations

12.

Kang, Ho Won, Young Joon Byun, Pildu Jeong, et al.. (2020). A novel urinary mRNA signature using the droplet digital polymerase chain reaction platform improves discrimination between prostate cancer and benign prostatic hyperplasia within the prostate-specific antigen gray zone. Investigative and Clinical Urology. 61(4). 411–411. 7 indexed citations

13.

Kang, Ho Won, Young Joon Byun, Xuan‐Mei Piao, et al.. (2019). Methylation Signature for Prediction of Progression Free Survival in Surgically Treated Clear Cell Renal Cell Carcinoma. Journal of Korean Medical Science. 34(19). e144–e144. 17 indexed citations

14.

Kang, Ho Won, Won Tae Kim, Seok Joong Yun, et al.. (2019). The age-adjusted Charlson comorbidity index as a predictor of overall survival of surgically treated non-metastatic clear cell renal cell carcinoma. Journal of Cancer Research and Clinical Oncology. 146(1). 187–196. 27 indexed citations

15.

Kang, Ho Won, Hae Do Jung, Joo Yong Lee, et al.. (2018). The Within-Group Discrimination Ability of the Cancer of the Prostate Risk Assessment Score for Men with Intermediate-Risk Prostate Cancer. Journal of Korean Medical Science. 33(5). e36–e36. 1 indexed citations

16.

Lee, Sin Woo, See Min Choi, Chunwoo Lee, et al.. (2018). Metabolic Syndrome Is an Independent Risk Factor for Acquired Premature Ejaculation. The World Journal of Men s Health. 37(2). 226–226. 15 indexed citations

17.

Kang, Ho Won, Won Tae Kim, Seok Joong Yun, et al.. (2016). Impact of Young Age at Diagnosis on Survival in Patients with Surgically Treated Renal Cell Carcinoma: a Multicenter Study. Journal of Korean Medical Science. 31(12). 1976–1976. 22 indexed citations

18.

Kang, Ho Won, Won Tae Kim, Yong‐June Kim, et al.. (2014). Effect of Renal Insufficiency on Stone Recurrence in Patients with Urolithiasis. Journal of Korean Medical Science. 29(8). 1132–1132. 13 indexed citations

19.

Kang, Ho Won, Phil Hyun Song, Yun‐Sok Ha, et al.. (2013). Glutathione S-transferase M1 and T1 polymorphisms: Susceptibility and outcomes in muscle invasive bladder cancer patients. European Journal of Cancer. 49(14). 3010–3019. 21 indexed citations

20.

Kim, Seon‐Kyu, Youngwon Kim, Ho Won Kang, et al.. (2012). Combined Hypermethylation of APC and GSTP1 as a Molecular Marker for Prostate Cancer: Quantitative Pyrosequencing Analysis. SLAS DISCOVERY. 17(7). 987–992. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact